IMPACT public forum in Singapore gets FDA/IFPMA backing
The International Medical Products Anti-Counterfeiting Task force (IMPACT) has announced that Singapore will be the site of its first public forum on February 13-15. The World Health Organization-led group will address the theme: Combating Counterfeit Medicines: Where the Regulatory and Technology Roads Meet, under the joint chairmanship of Ilisa Bernstein, Director of Pharmacy Affairs at the US Food and Drug Administration, and Harvey Bale, the International Federation of Pharmaceutical Manufacturers and Associations' director general.
Dr Bernstein said that "pharmaceutical manufacturers and regulators have an interest to keep themselves informed about developments and this IMPACT Forum should provide a handy means of doing so." Registration for the forum and additional information are available from the web site: www.impactglobalforum.org.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze